Clinical and biochemical study of 29 Brazilian patients with metachromatic leukodystrophy
- 2 July 2010
- journal article
- research article
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 33 (S3), 257-262
- https://doi.org/10.1007/s10545-010-9140-4
Abstract
Metachromatic leukodystrophy (MLD) is a lysosomal disorder caused by arylsulfatase A (ARSA) deficiency. It is classified into three forms according to the age of onset of symptoms (late infantile, ju...Keywords
This publication has 15 references indexed in Scilit:
- Metachromatic leukodystrophy: an overview of current and prospective treatmentsBone Marrow Transplantation, 2008
- Metachromatic leukodystrophy – mutation analysis provides further evidence of genotype–phenotype correlationClinical Genetics, 2008
- A clinical study of 77 patients with mucopolysaccharidosis type IIActa Paediatrica, 2007
- Gene therapy of metachromatic leukodystrophy reverses neurological damage and deficits in miceJCI Insight, 2006
- Peripheral neuropathy in metachromatic leucodystrophy. A study of 40 cases from south IndiaJournal of Neurology, Neurosurgery & Psychiatry, 2005
- Prevalence of lysosomal storage diseases in PortugalEuropean Journal of Human Genetics, 2003
- Consanguinity in South America: Demographic AspectsHuman Heredity, 2000
- The frequency of lysosomal storage diseases in The NetherlandsHuman Genetics, 1999
- Arylsulfatase A pseudodeficiency: loss of a polyadenylylation signal and N-glycosylation site.Proceedings of the National Academy of Sciences of the United States of America, 1989
- Metachromatic leucodystrophy: review of 38 cases.Archives of Disease in Childhood, 1982